Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
34 /100
MEDIUM RISK
Score updated Aug 28, 2026

CSBR — Champions Oncology, Inc. Dilution Risk Tracker

Track CSBR dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CSBR — Get alerts when the score changes →

As of August 28, 2026, Champions Oncology, Inc. (CSBR) has a DilutionWatch DilutionScore of 34/100, rated MEDIUM dilution risk. Champions Oncology, Inc. has a market capitalization of $81.03M, 13.89M shares outstanding, 26 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
62
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for CSBR.
🔔 Track CSBR — Get forecast alerts →

Market Data

Market Cap$81.03M
Shares Outstanding13.89M
Float5.19M
Cash$7.13M
DebtN/A
Short InterestN/A

Institutional Holdings

QoQ: ↑ 11.5% shares (2026Q1 vs prior)
26 institutional holders · 6.47M shares
#1 BATTERY MANAGEMENT CORP. 2.42M shares
#2 NEA Management Company, LLC 1.71M shares
#3 MORGAN STANLEY 661.6K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest76.2K
Days to Cover9.0
% of Float1.5%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2016-04-30
4 INSIDER TRANSACTION 2026-01-30
4 INSIDER TRANSACTION 2026-01-30
3 FORM3 2026-01-16
Full SEC filing analysis available with free account

Recent News

No recent news

Factual CSBR Dilution Snapshot

Champions Oncology, Inc. (CSBR) has a DilutionScore of 34/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track CSBR Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CSBR — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for CSBR
CSBR FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.